Virtual-first Musculoskeletal Health Management Program

See MSK risk earlier. Intervene sooner. Reduce avoidable downstream cost.

87%
Activated
87.7%
Retained
9.1/10
NPS
77.6%
Telehealth
check-circle Upstream screening + triage to match intensity to need
Physiotherapist-led support (not digital-only)
Cohort reporting designed for commissioning and scale
Download Report
Book a Demo
BTC the challenge
The Problem

 

MSK cost often shows up late, after function has dropped and care has escalated.

“In a risk equalisation environment, advantage comes less from who you insure, and more from how well you prevent chronicity, manage utilisation, and improve recovery outcomes.”

 
risks-1

icon-eye

Limited visibility upstream

Risk appears in claims, not early signals. By the time you see it, care has often escalated.

icon-pathways

Fragmented pathways

Low adherence to traditional conservative care and inconsistent outcomes across provider networks.

icon-costs

High-cost models

Models like Hospital in the Home (HITH) provide quality care but don't scale across the broader MSK population.

The Reality

Why this matters now
(risk equalisation reality)

Risk equalisation limits the upside of risk selection. Sustainable margin comes from better pathways that reduce avoidable utilisation, limit chronicity, and improve recovery outcomes at scale.

That’s exactly what this program is built to do.
download-app-email-1

Our Solution

A scalable, technology-enabled program that bridges the gap between screening and measurable outcomes.

solution-screen-2

Screen

Screen risk early with a Joint Health Profile (function + risk signals)

solution-match-2

Match

Match members to the right pathway (not one-size-fits-all)

solution-support-2

Support

Support with a qualified physio via structured digital care + telehealth

solution-measure-2

Measure

Measure outcomes with an insurer-ready reporting cadence

You don’t need to choose between quality and cost

The question is where high-touch care is used — and how early members are engaged.

Model
What it's good at
Where it breaks down
Hospital in the Home (HITH)
High Cost
What it's good at: High-touch support for admitted/substitution episodes
Where it breaks down: Expensive per episode, hard to scale, often used late
Digital-only MSK
Low Adherence
What it's good at: Low cost, easy deployment
Where it breaks down: Can feel impersonal, weaker adherence without human support
BTC Virtual-first + physio-led
Optimized
What it's good at: Earlier triage, human support built in, measurable outcomes
Where it breaks down: Designed to reduce unnecessary reliance on high-cost downstream models
  Pilot Data

Surgical comparison stream (early signals)

Exceptional onboarding and engagement results from recent pilot cohorts demonstrating readiness for scale.

88.2%
Onboarding
90.0%
Retention

What you receive

 

Upstream MSK visibility before avoidable escalation

 

A scalable service model members engage with (not 'another app')

 

Clear cohort reporting: uptake, retention, outcomes, escalations

 

Network-friendly delivery: doesn’t replace existing clinicians

How we start

Phase 1: Early Intervention

Upstream early intervention rollout to an agreed MSK cohort, with reporting built in.

Phase 2: Surgical Optimisation

Small surgical optimisation comparison stream to measure performance against your current pathway (including HITH where relevant).

Bood a demo to map your cohort
jason-circle
icon-quotation

“Patients value having a single source of support to self-manage, which improves confidence and reassurance.”


Dr Jason Tsung
Orthopaedic Surgeon
 

Quick FAQs

icon-download-1

Download the Project Mobilise Outcomes Report

Get the evidence insurers need to evaluate a virtual-first MSK program: engagement, retention, member experience, and early outcomes.

icon-bullet Engagement and retention data
Telehealth attendance rates
Member NPS and feedback
Early clinical outcome indicators


Includes commissioning-ready reporting for utilisation and recovery outcomes.

Book a Demo

See what rollout looks like for your cohort.